Evidence‐based rationale for low dose nivolumab in critically ill patients with sepsis‐induced immunosuppression

por van den Haak, Demy A. C., Otten, Leila‐Sophie, Koenen, Hans J. P. M., Smeets, Ruben L., Piet, Berber, Pickkers, Peter, Kox, Matthijs, ter Heine, Rob
Publicado 2023